The effect of β-adrenergic blockade and COX-2 inhibition on healing of colon, muscle, and skin in rats undergoing colonic anastomosis

International Journal of Clinical Pharmacology and Therapeutics

Volumn 49, Issue 9, 2011, Pages 545-554

  Hazut, O ^a   Shaashua, L ^a   Benish, M ^a   Levi, B ^a   Sorski, L ^a   Benjamin, B ^b   Hoffman, A ^c   Zmora, O ^c   Ben Eliyahu, S ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b MEIR MEDICAL CENTER   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

adrenergic blockers; Colonic anastomosis; COX 2 inhibitors; Perioperative

Indexed keywords

ETODOLAC; PLACEBO; PROPRANOLOL;

ABDOMINAL WALL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CANCER SURGERY; COLON ANASTOMOSIS; COLON CANCER; COLONIC BURSTING PRESSURE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG SAFETY; ENZYME INHIBITION; FEMALE; INTESTINE MUSCLE; INTESTINE PRESSURE; LAPAROTOMY; MALE; MENTAL STRESS; NONHUMAN; PUNCH BIOPSY; RAT; SKIN; TENSILE STRENGTH; WEIGHT REDUCTION; WOUND HEALING;

ABDOMINAL WALL; ADRENERGIC BETA-ANTAGONISTS; ANASTOMOSIS, SURGICAL; ANIMALS; COLON; CYCLOOXYGENASE 2 INHIBITORS; ETODOLAC; FEMALE; LAPAROTOMY; MALE; POSTOPERATIVE COMPLICATIONS; PROPRANOLOL; RATS; RATS, INBRED F344; SKIN; TENSILE STRENGTH; WEIGHT LOSS; WOUND HEALING;

EID: 80052980222     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CP201550     Document Type: Article

References (67)

1. Antoni MH, Lutgendorf SK, Cole SW, Dhabhar FS, Sephton SE, McDonald PG, Stefanek M, Sood AK. The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer. 2006; 6: 240-248. doi:10.1038/nrc1820 PubMed (Pubitemid 43292567)
2. Ben-Eliyahu S, Page GG, Yirmiya R, Shakhar G. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer. 1999; 80: 880-888. doi:10.1002/(SICI)1097-0215(19 99031 5) 80:6 < 880::AID-IJC14 > 3.0.CO;2-Y PubMed
3. Buinauskas P, McDONALD GO, Cole WH. Role of operative stress on the resistance of the experimental animal to inoculated cancer cells. Ann Surg. 1958; 148: 642-645, discussion 645-648. doi:10.1097/00000658-195810000-00011 PubMed
4. Eggermont AM et al. Local regional promotion of tumor growth after abdominal surgery is dominant over immunotherapy with interleukin-2 and lymphokine activated killer cells. Cancer Detect Prev. 1988; 12: 421-429.
5. Fielding LP, Wells BW. Survival after primary and after staged resection for large bowel obstruction caused by cancer. Br J Surg. 1974; 61: 16-18. doi:10.1002/bjs.1800610105 PubMed
6. Shakhar G, Ben-Eliyahu S. Potential prophylactic measures against postoperative immuno suppression: could they reduce recurrence rates in oncological patients? Ann Surg Oncol. 2003; 10: 972-992. doi:10.1245/ASO.2003. 02.007 PubMed (Pubitemid 40486865)
7. Sietses C, Beelen RH, Meijer S, Cuesta MA. Immunological consequences of laparoscopic surgery, speculations on the cause and clinical implications. Langenbecks Arch Surg. 1999; 384: 250-258. doi:10.1007/s004230050200 PubMed (Pubitemid 29309068)
8. Weese JL, Ottery FD, Emoto SE. Do operations facilitate tumor growth? An experimental model in rats. Surgery. 1986; 100: 273-277. PubMed (Pubitemid 16070860)
9. Benish M, Bartal I, Goldfarb Y, Levi B, Avraham R, Raz A, Ben-Eliyahu S. Perioperative use of betablockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Ann Surg Oncol. 2008; 15: 2042-2052. doi:10.1245/s10434-008-9890-5 PubMed
10. Glasner A et al. Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor. J Immunol. 2010; 184: 2449-2457.
11. Melamed R, Rosenne E, Shakhar K, Schwartz Y, Abudarham N, Ben-Eliyahu S. Marginating pulmonary- NK activity and resistance to ex perimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor. Brain Behav Immun. 2005; 19: 114-126. doi:10.1016/j.bbi.2004.07.004 PubMed (Pubitemid 40138646)
12. Witte MB, Barbul A. General principles of wound healing. Surg Clin North Am. 1997; 77: 509-528. doi:10.1016/S0039-6109(05)70566-1 PubMed (Pubitemid 27256032)
13. Fielding LP, Stewart-Brown S, Blesovsky L, Kearney G. Anastomotic integrity after operations for large-bowel cancer: a multicentre study. BMJ. 1980; 281: 411-414. doi:10.1136/bmj.281.6237.411 PubMed (Pubitemid 10093062)
14. Goligher JC, Graham NG, De Dombal FT. Anastomotic dehiscence after anterior resection of rectum and sigmoid. Br J Surg. 1970; 57: 109-118. doi:10.1002/bjs.1800570208 PubMed
15. Golub R, Golub RW, Cantu R Jr, Stein HD. A multivariate analysis of factors contributing to leakage of intestinal anastomoses. J Am Coll Surg. 1997; 184: 364-372. PubMed (Pubitemid 27172822)
16. Karanjia ND, Corder AP, Holdsworth PJ, Heald RJ. Risk of peritonitis and fatal septicaemia and the need to defunction the low anastomosis. Br J Surg. 1991; 78: 196-198. doi:10.1002/bjs.1800780221 PubMed
17. Morgenstern L, Yamakawa T, Ben-Shoshan M, Lippman H. Anastomotic leakage after low colonic anastomosis. Clinical and experimental aspects. Am J Surg. 1972; 123: 104-109. doi:10.1016/0002-9610(72)90317-0 PubMed
18. Camu F, Shi L, Vanlersberghe C. The role of COX-2 inhibitors in pain modulation. Drugs. 2003; 63 (Suppl 1): 1-7. doi:10.2165/00003495-200363001-00002 PubMed (Pubitemid 36801792)
19. Rømsing J, Møiniche S. A systematic review of COX-2 inhibitors compared with traditional NSAIDs, or different COX-2 inhibitors for postoperative pain. Acta Anaesthesiol Scand. 2004; 48: 525-546. doi:10.1111/j.0001-5172.2004.00379.x PubMed (Pubitemid 38649583)
20. Bernadt MW, Silverstone T, Singleton W. Behavioural and subjective effects of beta-adrenergic blockade in phobic subjects. Br J Psychiatry. 1980; 137: 452-457. doi:10.1192/bjp.137.5.452 PubMed (Pubitemid 10030110)
21. Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med. 1998; 339: 489-497. doi:10.1056/NEJM199808203390801 PubMed (Pubitemid 28384881)
22. Smith WL, DeWitt DL, Garavito RM. Cyclo oxygenases: structural, cellular, and molecular biology. Annu Rev Biochem. 2000; 69: 145-182. doi:10.1146/annurev.biochem.69.1.145 PubMed
23. Jiang C, Ting AT, Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature. 1998; 391: 82-86. doi:10.1038/35154 PubMed (Pubitemid 28079219)
24. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator-activated receptorgamma is a negative regulator of macrophage activation. Nature. 1998; 391: 79-82. doi:10.1038/34178 PubMed (Pubitemid 28079218)
25. Souza BR, Santos JS, Costa AM. Blockade of beta1- and beta2-adrenoceptors delays wound contraction and re-epithelialization in rats. Clin Exp Pharmacol Physiol. 2006; 33: 421-430. doi:10.1111/j.1440-1681.2006.04383.x PubMed
26. Blomme EA, Chinn KS, Hardy MM, Casler JJ, Kim SH, Opsahl AC, Hall WA, Trajkovic D, Khan KN, Tripp CS. Selective cyclooxygenase-2 inhibition does not affect the healing of cutaneous fullthickness incisional wounds in SKH-1 mice. Br J Dermatol. 2003; 148: 211-223. doi:10.1046/j.1365- 2133.2003.05065.x PubMed
27. Müller-Decker K, Hirschner W, Marks F, Fürstenberger G. The effects of cyclooxygenase iso zyme inhibition on incisional wound healing in mouse skin. J Invest Dermatol. 2002; 119: 1189-1195. doi:10.1046/j.1523-1747. 2002.19501.x PubMed (Pubitemid 35430498)
28. Törkvist L, Månsson P, Raud J, Larsson J, Thorlacius H. Role of CD18-dependent neutrophil recruitment in skin and intestinal wound healing. Eur Surg Res. 2001; 33: 249-254. doi:10.1159/000049714 PubMed (Pubitemid 34701884)
29. Gilroy DW, Colville-Nash PR, Willis D, Chivers J, Paul-Clark MJ, Willoughby DA. Inducible cyclo-oxygenase may have anti-inflammatory properties. Nat Med. 1999; 5: 698-701. doi:10.1038/9550 PubMed
30. Emery P, Zeidler H, Kvien TK, Guslandi M, Naudin R, Stead H, Verburg KM, Isakson PC, Hubbard RC, Geis GS. Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison. Lancet. 1999; 354: 2106-2111. doi: 10.1016/S0140-6736(99)02332-6 PubMed (Pubitemid 30008893)
31. Feldman M, McMahon AT. Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity? Ann Intern Med. 2000; 132: 134-143. PubMed (Pubitemid 30044181)
32. Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrawal NM, Stenson WF, Burr AM, Zhao WW, Kent JD, Lefkowith JB, Verburg KM, Geis GS. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti- inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA. 2000; 284: 1247-1255. doi:10.1001/jama.284.10.1247 PubMed
33. Endo K, Sairyo K, Komatsubara S, Sasa T, Egawa H, Ogawa T, Yonekura D, Murakami R, Yasui N. Cyclooxygenase-2 inhibitor delays fracture healing in rats. Acta Orthop. 2005; 76: 470-474. doi:10.1080/17453670510041439 PubMed (Pubitemid 41232775)
34. Seidenberg AB, An YH. Is there an inhibitory effect of COX-2 inhibitors on bone healing? Pharmacol Res. 2004; 50: 151-156. doi:10.1016/j.phrs.2003.12. 017 PubMed (Pubitemid 38737246)
35. Futagami A, Ishizaki M, Fukuda Y, Kawana S, Yamanaka N. Wound healing involves induction of cyclooxygenase-2 expression in rat skin. Lab Invest. 2002; 82: 1503-1513. PubMed (Pubitemid 35332909)
36. Laulederkind SJ, Thompson-Jaeger S, Goorha S, Chen Q, Fu A, Rho JY, Ballou LR, Raghow R. Both constitutive and inducible prostaglandin H synthase affect dermal wound healing in mice. Lab Invest. 2002; 82: 919-927. PubMed (Pubitemid 34761667)
37. Brennan SS, Foster ME, Morgan A, Leaper DJ. Prostaglandins in colonic anastomotic healing. Dis Colon Rectum. 1984; 27: 723-725. doi:10.1007/BF02554598 PubMed
38. De Sousa JB, Soares EG, Aprilli F. Effects of diclofenac sodium on intestinal anastomotic healing. Experimental study on the small intestine of rabbits. Dis Colon Rectum. 1991; 34: 613-617. doi:10.1007/BF02049903 PubMed
39. Terzioglu T, Sonmez YE, Eldegez U. The effect of prostaglandin E1 on colonic anastomotic healing. A comparison study. Dis Colon Rectum. 1990; 33: 44-48. doi:10.1007/BF02053201 PubMed (Pubitemid 20054307)
40. Cahill RA, Sheehan KM, Scanlon RW, Murray FE, Kay EW, Redmond HP. Effects of a selective cyclo- oxygenase 2 inhibitor on colonic anas tomotic and skin wound integrity. Br J Surg. 2004; 91: 1613-1618. doi:10.1002/bjs.4722 PubMed (Pubitemid 39619925)
41. De Hingh IH, Van Goor H, De Man BM, Lomme RM, Bleichrodt RP, Hendriks T. Selective cyclooxygenase 2 inhibition affects ileal but not colonic anastomotic healing in the early postoperative period. Br J Surg. 2006; 93: 489-497. doi:10.1002/bjs.5288 PubMed
42. Hart DW, Wolf SE, Chinkes DL, Lal SO, Ramzy PI, Herndon DN. Beta-blockade and growth hormone after burn. Ann Surg. 2002; 236: 450-456, discussion 456-457. doi:10.1097/00000658-20021000 0-00007 PubMed
43. Romana-Souza B, Nascimento AP, Monte-Alto- Costa A. Propranolol improves cutaneous wound healing in streptozotocin-induced diabetic rats. Eur J Pharmacol. 2009; 611: 77-84. doi:10.1016/j.ejphar.2009.03.053 PubMed
44. Shi JM, Lai SG, Xu CJ, Duan GL, Li D. Pharmacokinetic difference between S-(+)- and R-(-)- etodolac in rats. Acta Pharmacol Sin. 2004; 25: 996-999. PubMed
45. Jones MK, Wang H, Peskar BM, Levin E, Itani RM, Sarfeh IJ, Tarnawski AS. Inhibition of angio- genesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med. 1999; 5: 1418-1423. doi:10.1038/70995 PubMed
46. Rozic JG, Chakraborty C, Lala PK. Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis. Int J Cancer. 2001; 93: 497-506. doi:10.1002/ijc.1376 PubMed (Pubitemid 32701408)
47. Wei D, Wang L, He Y, Xiong HQ, Abbruzzese JL, Xie K. Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity. Cancer Res. 2004; 64: 2030-2038. doi:10.1158/0008-5472.CAN-03- 1945 PubMed (Pubitemid 38339450)
48. Roche-Nagle G, Connolly EM, Eng M, Bouchier- Hayes DJ, Harmey JH. Antimetastatic activity of a cyclooxygenase-2 inhibitor. Br J Cancer. 2004; 91: 359-365. PubMed (Pubitemid 39037084)
49. Kern MA, Haugg AM, Koch AF, Schilling T, Breuhahn K, Walczak H, Fleischer B, Trautwein C, Michalski C, Schulze-Bergkamen H, Friess H, Stremmel W, Krammer PH, Schirmacher P, Müller M. Cyclooxygenase-2 inhibition induces apop tosis signaling via death receptors and mitochondria in hepatocellular carcinoma. Cancer Res. 2006; 66: 7059-7066. doi:10.1158/0008-5472.CAN-06-0325 PubMed (Pubitemid 44197682)
50. Sinicrope FA, Gill S. Role of cyclooxygenase-2 in colorectal cancer. Cancer Metastasis Rev. 2004; 23: 63-75. doi:10.1023/A:1025863029529 PubMed (Pubitemid 38221596)
51. Sood AK, Bhatty R, Kamat AA, Landen CN, Han L, Thaker PH, Li Y, Gershenson DM, Lutgendorf S, Cole SW. Stress hormone-mediated invasion of ovarian cancer cells. Clin Cancer Res. 2006; 12: 369-375. doi:10.1158/1078-0432. CCR-05-1698 PubMed (Pubitemid 43166123)
52. Yang EV, Kim SJ, Donovan EL, Chen M, Gross AC, Webster Marketon JI, Barsky SH, Glaser R. Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression. Brain Behav Immun. 2009; 23: 267-275. doi:10.1016/j.bbi. 2008.10.005 PubMed
53. Elenkov IJ. Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being. Neurochem Int. 2008; 52: 40-51. doi:10.1016/j.neuint.2007.06.037 PubMed (Pubitemid 350235704)
54. Shakhar G, Ben-Eliyahu S. In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats. J Immunol. 1998; 160: 3251-3258. (Pubitemid 28164714)
55. Masur K, Niggemann B, Zanker KS, Entschladen F. Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers. Cancer Res. 2001; 61: 2866-2869. PubMed (Pubitemid 32691927)
56. Thaker PH, Han LY, Kamat AA, Arevalo JM, Takahashi R, Lu C, Jennings NB, Armaiz-Pena G, Bankson JA, Ravoori M, Merritt WM, Lin YG, Mangala LS, Kim TJ, Coleman RL, Landen CN, Li Y, Felix E, Sanguino AM, Newman RA, et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med. 2006; 12: 939-944. doi:10.1038/nm1447 PubMed (Pubitemid 44175146)
57. Yang EV, Sood AK, Chen M, Li Y, Eubank TD, Marsh CB, Jewell S, Flavahan NA, Morrison C, Yeh PE, Lemeshow S, Glaser R. Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res. 2006; 66: 10357-10364. doi:10.11 58/0008-5472.CAN-06-2496 PubMed
58. Levenson SM, Geever EF, Crowley LV, Oates JF III, Berard CW, Rosen H. The Healing of Rat Skin Wounds. Ann Surg. 1965; 161: 293-308. doi:10.1097/00000658- 196502000-00019 PubMed
59. Jiborn H, Ahonen J, Zederfeldt B. Healing of experimental colonic anastomoses. I. Bursting strength of the colon after left colon resection and anastomosis. Am J Surg. 1978; 136: 587-594. doi:10.1016/0002-9610(78)90315-X PubMed (Pubitemid 9071753)
60. Wilgus TA, Vodovotz Y, Vittadini E, Clubbs EA, Oberyszyn TM. Reduction of scar formation in full-thickness wounds with topical celecoxib treatment. Wound Repair Regen. 2003; 11: 25-34. doi:10.1046/j.1524-475X.2003.11106.x PubMed (Pubitemid 36268606)
61. Wilgus TA, Ross MS, Parrett ML, Oberyszyn TM. Topical application of a selective cyclooxygenase inhibitor suppresses UVB mediated cutaneous inflammation. Prostaglandins Other Lipid Mediat. 2000; 62: 367-384. doi:10.1016/S0090-6980(00)00089-7 PubMed
62. Hendriks T, Mastboom WJ. Healing of experimental intestinal anastomoses. Parameters for repair. Dis Colon Rectum. 1990; 33: 891-901. doi:10.1007/ BF02051930 PubMed (Pubitemid 20350511)
63. Dhabhar FS et al. Effects of stress on immune cell distribution. Dynamics and hormonal mechanisms. J Immunol. 1995; 154: 5511-5527.
64. Sheridan JF, Padgett DA, Avitsur R, Marucha PT. Experimental models of stress and wound healing. World J Surg. 2004; 28: 327-330. doi:10.1007/s00268- 003-7404-y PubMed (Pubitemid 38375538)
65. Inbar S, Neeman E, Avraham R, Benish M, Rosenne E, Ben-Eliyahu S. Do Stress Responses Promote Leukemia Progression? An Animal Study Suggesting a Role for Epinephrine and Prostaglandin-E(2) through Reduced NK Activity. PLoS ONE. 2011; 6: e19246. doi:10.1371/journal.pone.0019246 PubMed
66. Benish M, Ben-Eliyahu S. Surgery as a doubleedged sword: A clinically feasible approach to overcome the metastasis-promoting effects of surgery by blunting stress and prostaglandin responses. Cancers. 2010; 2: 1929-1951. doi:10.3390/cancers2041929
67. Warner TD, Giuliano F, Vojnovic I, Bukasa A, Mitchell JA, Vane JR. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase- 2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci USA. 1999; 96: 7563-7568. doi:10.1073/pnas.96.13. 7563 PubMed (Pubitemid 29299702)